Trends in XXXX factor prevalence (1995-2000-2005) in northeastern Spain.

@entity1 @entity101 @entity28 @entity6 @entity583 @entity65 @entity165
BACKGROUND: High prevalence of @entity65 factors has been observed in Spain along with low incidence of @entity583 . Our objective was to determine the trends of @entity65 factor prevalence between 1995 and 2005 in the 35-74-year-old population of Gerona, Spain. DESIGN: Comparison of cross-sectional studies were conducted in random population samples in 1995, 2000, and 2005 at Gerona, Spain. METHODS: An electrocardiogram was obtained, along with standardized measurements of body mass index, lipid profile, systolic and diastolic blood pressure, glycaemia, energy expenditure in physical activity, smoking, use of lipid-lowering and antihypertensive medications, and @entity65 . Prevalence of @entity6 , @entity101 , and @entity28 was calculated and standardized for age. RESULTS: A total of 7571 individuals (52.0% @entity1 ) were included (response rate 72%). Low-density lipoprotein @entity165 >3.4 mmol/l (130 mg/dl) (49.7%) and @entity101 (39.1%) were the most prevalent @entity65 factors. In 1995, 2000 and 2005, low-density lipoprotein @entity165 decreased in both @entity1 and @entity1 : 4.05-3.91-3.55 mmol/l (156-151-137 mg/dl) and 3.84-3.81-3.40 mmol/l (148-147-131 mg/dl), respectively. Increases were observed in lipid-lowering drug use (5.7-6.3-9.6% in @entity1 and 4.0-5.8-8.0% in @entity1 ), controlled @entity101 (14.8-35.4-37.7% in @entity1 and 21.3-36.9-45.0% in @entity1 ); (all P-trends <0.01), and @entity28 (greatest for @entity1 : 17.5-26.0-22.7%, P-trends=0.020). Prevalence of @entity583 or possibly abnormal Q waves in electrocardiogram also increased significantly (3.9-4.7-6.4%, P-trends=0.018). CONCLUSIONS: The @entity65 factor prevalence change in Gerona was marked in this decade by a shift of total @entity165 and low-density lipoprotein @entity165 distributions to the left, independent of the increase in lipid-lowering drug use, and better @entity101 control with increased use of antihypertensive drugs.
